CD46 protects the bladder cancer cells from cetuximab-mediated cytotoxicity

Epidermal growth factor receptor (EGFR) is an effective target for those patients with metastatic colorectal cancers that retain the wild-type RAS gene. However, its efficacy in many cancers, including bladder cancer, is unclear. Here, we studied the in vitro effects of cetuximab monoclonal antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Do, Manh-Hung, Thanh, Hien Duong, To, Phuong Kim, Kim, Min Soo, Moon, Changjong, Jung, Chaeyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794803/
https://www.ncbi.nlm.nih.gov/pubmed/36575233
http://dx.doi.org/10.1038/s41598-022-27107-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794803/
https://www.ncbi.nlm.nih.gov/pubmed/36575233
http://dx.doi.org/10.1038/s41598-022-27107-9

Ejemplares similares